New Drugs for Malignancy, an Issue of Hematology/Oncology Clinics of North America

by Franco Muggia

Topics Targeting IGF-1R, Tyrosine Kinase Inhibitors in Lung Cancer, Targeting mTOR, Targeting Hedgehog, Mitotic Inhibitors, Topoisomerase I Inhibitors, and New Strategies and Drugs Inhibiting Folate Pathways.

1440 pages, Kindle Edition

First published May 8, 2012